Functionalised and chelate heterocyclic carbene complexes of palladium; synthesis and structural studiesElectronic supplementary information (ESI) available: crystallographic data and ORTEP plots for complexes 4, 7, 8 and 13. See http://www.rsc.org/suppdata/dt/b2/b209231j/
作者:Arran A. D. Tulloch、Scott Winston、Andreas A. Danopoulos、Graham Eastham、Michael B. Hursthouse
DOI:10.1039/b209231j
日期:2003.2.11
A series of picolyl-functionalised, [(C^N)PdXY], 1a, 2a, 3a and 4, pyridyl-functionalised, [(C–N)PdXY], 5a, 6, 7 and 8, methoxymethyl-functionalised, [(C^O)Pd(μ-X)X]2, 10, and trans-[(C^O)2PdX2], 11, and diethylcarbamoylmethyl-functionalised, trans-[(C^amide)2PdX2], 12, N-heterocyclic carbene (NHC) complexes of palladium(II), (C^N)
=
(3-R1)[1-(α-picolyl)imidazol-2-ylidene, (C–N)
=
(3-R1)[1-(2-pyridyl)imidazol-2-ylidene, R1
= But, mesityl, 2,6-Pri2C6H3, (C^O)
=
(3-R1)(1-methoxymethyl)imidazol-2-ylidene, R1
= 2,6-Pri2C6H3, (C^amide)
=
(3-R1)(1-diethylcarbamoylmethyl)imidazol-2-ylidene, R1
= 2,6-Pri2C6H3, Y = Me, X = Br or Cl, have been synthesised by interaction of (1,5-cod)PdXY or (1,5-cod)PdX2 with the corresponding silver NHC complexes, or (in certain cases) with the free functionalised NHC ligands. Derivatives of 1a, 2a, 3a and 5a were prepared by substitution of the halide X by weakly coordinating anions. The majority of the complexes described here were characterised by spectroscopic and diffraction methods and show that the (C–N) and (C^N) ligands act as chelates, while the methoxymethyl- and diethylcarbamoylmethyl-functions in 10, 11 and 12, respectively, are dangling. Derivatives of 5a in which the pyridine ring is substituted with electron withdrawing or bulky substituents show only minor variation of the pyridine–palladium distances.
一系列
吡啶基官能化,[(C^N)PdXY]、1a、2a、3a 和 4,
吡啶基官能化,[(C–N)PdXY]、5a、6、7 和 8,甲氧基甲基官能化,[ (C^O)Pd(μ-X)X]2、10 和反式-[(C^O)2PdX2]、11 和
二乙基氨基甲酰甲基官能化、反式-[(C^酰胺)2PdX2]、12、N -
钯(II)的杂环卡宾(NHC)络合物,(C^N)
=
(3-R1)[1-(α-
吡啶甲基)
咪唑-2-亚基,(C–N)
=
(3-R1)[1-(2-
吡啶基)
咪唑-2-亚基,R1
= 但是,异丙叉,2,6-Pri2C6H3,(C^O)
=
(3-R1)(1-甲氧基甲基)
咪唑-2-亚基,R1
= 2,6-Pri2C6H3, (C^酰胺)
=
(3-R1)(1-
二乙基氨基甲酰基甲基)
咪唑-2-亚基,R1
= 2,6-Pri2C6H3,Y = Me,X = Br 或 Cl,通过 (1,5-cod)PdXY 或 (1,5-cod)PdX2 与相应的
银 NHC 配合物相互作用合成,或(在某些情况下)与游离功能化 NHC
配体。通过用弱配位阴离子取代卤化物X来制备1a、2a、3a和5a的衍
生物。本文描述的大多数配合物均通过光谱和衍射方法进行了表征,并表明 (C–N) 和 (C^N)
配体充当螯合物,而甲氧基甲基和
二乙基氨基甲酰甲基功能分别在 10、11 和 12 中,悬空。 5a 的衍
生物,其中
吡啶环被吸电子或大体积取代基取代,仅显示
吡啶-
钯距离的微小变化。